Inflammatory [ftcn]
activity [dora]
Antibodies, Anticardiolipin [aapp, imft]
tibolone [phsu, strd]
treatment [ftcn]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Study [mnob]
investigate [ftcn]
Inflammatory [ftcn]
activity [dora]
Antibodies, Anticardiolipin [aapp, imft]
ACT [topp]
tibolone [phsu, strd]
Administration [ocac]
twenty [orch, phsu]
Seven [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
included [ftcn]
Study [mnob]
divided [ftcn]
Group [idcn]
Women [popg]
Age-Years [tmco]
Received [qlco]
tibolone [phsu, strd]
Dose [qnco]
2 5 [qnco]
mg day [qnco]
months [tmco]
untreated [fndg]
Control Group [grup]
N NOS [aapp, imft]
Age-Years [tmco]
ACT [topp]
Isotype [aapp, imft]
C-reactive protein [aapp, imft]
baseline [bodm]
months [tmco]
treatment [ftcn]
ACT [topp]
tibolone [phsu, strd]
treatment [ftcn]
C-reactive protein [aapp, imft]
Increased [qnco]
1st [qnco]
3rd [qnco]
Compared [acty]
baseline [bodm]
Values [qlco]
Preliminary [tmco]
tibolone [phsu, strd]
Administration [ocac]
ACT [topp]
Counterbalance [mnob]
influential [idcn]
C-reactive protein [aapp, imft]
Science [ocdi]
Reserve [acty]
